Key topics will cover:
-Ispy 2 and collaborative trials
-Regulatory update: The FDA's take on adaptive design clinical trials for drugs and biologics
- Adaptive design in late phase designs
- Adaptive Seamless Designs
- Bayesian meta analysis
-Ispy 2 and collaborative trials
-Regulatory update: The FDA's take on adaptive design clinical trials for drugs and biologics
- Adaptive design in late phase designs
- Adaptive Seamless Designs
- Bayesian meta analysis
